Interstitial lung disease in systemic sclerosis. [electronic resource]
Producer: 20110801Description: 248-55 p. digitalISSN:- 1873-0183
- Antibodies, Monoclonal, Murine-Derived -- therapeutic use
- Autoantibodies -- immunology
- Azathioprine -- therapeutic use
- Contraindications
- Cyclophosphamide -- therapeutic use
- DNA Topoisomerases, Type I -- immunology
- Four-Dimensional Computed Tomography
- Gastroesophageal Reflux -- complications
- Humans
- Immunosuppressive Agents -- therapeutic use
- Lung -- immunology
- Lung Diseases, Interstitial -- diagnosis
- Lung Transplantation
- Mycophenolic Acid -- analogs & derivatives
- Prognosis
- Pulmonary Fibrosis -- complications
- Randomized Controlled Trials as Topic
- Respiratory Function Tests
- Rituximab
- Scleroderma, Systemic -- complications
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.